FDA to hold two Precision Medicine workshops; Hill-Rom completes Welch Allyn buy;

@FierceMedDev: Cofactor Genomics chases consumer testing with RNA diagnostic. More from FierceDiagnostics | Follow @FierceMedDev

@VarunSaxena2: $1M+ raised on Indiegogo for company making maskless device for sleep apnea. Article | Follow @VarunSaxena2

@EmilyWFierce: Scientists NASA turbocharge 3-D imaging device for minimally invasive surgeries. Article | Follow @EmilyWFierce

> The FDA will hold two more Precision Medicine Initiative workshops on Nov. 12-13 that will address analytical performance evaluation standards and clinical validation for next-generation sequencing. Blog post

> Hill-Rom has completed its $2 billion acquisition of Welch Allyn. More

> LabStyle Innovations has raised $2.5 million for a U.S. launch of its Dario blood glucose monitor. More

Biotech News

@FierceBiotech: Star team at Wyss, MIT orchestrate wider use of CRISPR/Cas9 tech. FierceBiotechResearch article | Follow @FierceBiotech

@JohnCFierce: And to mark 3 trial disasters in a row: Flexion routed as lead pain drug flops in first pivotal study. Article | Follow @JohnCFierce

@DamianFierce: ICYMI: NYT editorial takes a weird, non-systemic middle ground on PCSK9 pricing. Article | Follow @DamianFierce

> Roche backs AveXis in a $65M round for SMA gene therapy. Article

> Agenus mortgages some vaccine royalties for $115M in R&D cash. More

> On a crash course with Celgene? Biogen inks a $544M autoimmune drug deal. Story

> On the ropes, GlaxoSmithKline admits to another PhIII debacle. Report

Pharma News

@FiercePharma: Join @JohnCFierce for expert discussion on trial design and more at the @FierceBiotech Executive Summit on Oct. 12. More info | Follow @FiercePharma

@CarlyHFierce: ICYMI yesterday: Deal stalker Concordia snaps up Amdipharm in 'pivotal turning point' for M&A strategy. Article | Follow @CarlyHFierce

> Cost watchdog says PCSK9 meds should cost 85% less. Realistic or not? Story

> Roche CEO: Despite China worries, emerging markets will continue to deliver growth. Article

> Ireland plant with 100 workers on Sun's list for sale or closure. Item

Biotech Research News

> UC San Diego study IDs experimental drug for rare neurological disease. More

> Penn scientists identify viral products that defend against respiratory syncytial virus. Story

> Researchers zero in on tau, a prime culprit in Alzheimer's disease. Item

> Michigan team spotlights a new drug target for depression. Article

> Star team at Wyss, MIT orchestrate wider use of CRISPR/Cas9 tech. Report

Diagnostics News

> FDA clears Nanosphere's respiratory pathogens diagnostic test. News

> FDA pencils in two public meetings for NGS regulation. Item

> Moffitt Cancer Center, Signal Genetics to conduct 'precision medicine' study of myeloma patients. Report

> Beleaguered HDL mulls $32M sale to True Health amid bankruptcy. Story

> Cofactor Genomics chases consumer testing with RNA diagnostic. Article

Pharma Marketing News

> Big Pharma misses the cut for new list of top healthcare tweeters. More

> Sanofi agrees to pay $2.4M to Zaltrap sales reps in fight over discounted commissions. Report

> J&J's new multiple myeloma fighter gets FDA priority review. Item

> Bristol-Myers oncology team gears up for cycling fundraiser. Story

> Kardashian's FDA infraction shows policing pharma social media isn't easy. Article